These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Preload-dependent hemodynamic effects of milrinone in moderate heart failure. Remme WJ, van Hoogenhuyze DC, Kruijssen HA, Pieper PG, Bruggeling WA. Cardiology; 1992 Oct; 80(2):132-42. PubMed ID: 1611632 [Abstract] [Full Text] [Related]
45. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043. Uretsky BF, Valdes AM, Reddy PS. Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328 [Abstract] [Full Text] [Related]
46. Regional blood flow and neurohormonal responses to milrinone in congestive heart failure. Cody RJ, Kubo SH, Covit AB, Müller FB, Rutman H, Leonard D, Laragh JH, Feldschuh J, Preibisz J. Clin Pharmacol Ther; 1986 Feb; 39(2):128-35. PubMed ID: 3510799 [Abstract] [Full Text] [Related]
48. Hemodynamic and hormonal effects of the angiotensin II antagonist, candesartan cilexetil, in patients with congestive heart failure. Yoshimura M, Yasue H. Cardiology; 2000 Feb; 93(3):175-82. PubMed ID: 10965089 [Abstract] [Full Text] [Related]
51. Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failure. Jafri SM, Burlew BS, Goldberg AD, Rogers A, Goldstein S. Am J Cardiol; 1986 Feb 01; 57(4):254-9. PubMed ID: 3511661 [Abstract] [Full Text] [Related]
53. Hemodynamic effects of a constant intravenous infusion of piroximone in patients with severe congestive heart failure. Miller WE, Kennedy GT, Ruberg SJ, O'Rourke RA, Crawford MH. J Cardiovasc Pharmacol; 1988 Jul 01; 12(1):72-7. PubMed ID: 2459538 [Abstract] [Full Text] [Related]
54. Acute hemodynamic and neurohumoral effects of moxonidine in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Dickstein K, Manhenke C, Aarsland T, Køpp U, McNay J, Wiltse C. Am J Cardiol; 1999 Jun 15; 83(12):1638-44. PubMed ID: 10392868 [Abstract] [Full Text] [Related]
55. Acute hemodynamic effects of adibendan, a new phosphodiesterase inhibitor, for severe congestive heart failure. Voelker W, Mauser M, Preisack M, Karsch KR. Am J Cardiol; 1989 Aug 01; 64(5):390-2. PubMed ID: 2756885 [No Abstract] [Full Text] [Related]
57. Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure. Amin DK, Shah PK, Hulse S, Shellock F. Am Heart J; 1985 May 01; 109(5 Pt 1):1006-12. PubMed ID: 3158182 [Abstract] [Full Text] [Related]